Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach-Reference-Cited by-同舟云学术

Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach

Published:2023-12 Issue:12 Volume:26 Page:1721-1729
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Serra-Burriel Miquel,Aebersold Helena,Foster-Witassek Fabienne,Coslovsky Michael,Rodondi Nicolas,Blum Manuel R.,Sticherling Christian,Moschovitis Giorgio,Beer Jürg H.,Reichlin Tobias,Krisai Philipp,Aeschbacher Stefanie,Paladini Rebecca E.,Kühne Michael,Osswald Stefan,Conen David,Felder Stefan,Schwenkglenks Matthias

Funder

Foundation for Cardiovascular Research

Universität Basel

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Schweizerische Herzstiftung

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference28 articles.

1. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia;Kumar;Europace,2013

2. Surveys and registries on catheter ablation of atrial fibrillation: fifteen years of history;Cappato;Circ Arrhythm Electrophysiol,2021

3. Cryoablation or drug therapy for initial treatment of atrial fibrillation;Andrade;N Engl J Med,2021

4. Early rhythm-control therapy in patients with atrial fibrillation;Kirchhof;N Engl J Med,2020

5. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial;Mark;JAMA,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort;Open Heart;2024-01